Zusammenfassung
Neuroendokrine Tumoren der Lunge können heute unter Berücksichtigung immunhistochemischer Zusatzbefunde in Biopsie- und Operationspräparaten zuverlässig als eigene Entität der Lungentumoren entsprechend den Empfehlungen der WHO-Klassifikation 1999 zusammengefasst werden.
Die für klinische Fragestellungen und therapeutische Maßnahmen differenzierte Charakterisierung von Karzinoidtumoren und kleinzelligen Karzinomen nach histomorphologischen und zytologischen Kriterien durch den Pathologen ist allgemein akzeptiert und von entscheidender Bedeutung.
Unklar bleibt bisher, ob die "neue" Gruppe der großzelligen neuroendokrinen Karzinome der Lunge eine eigene Tumorentität mit klinischer und therapeutischer Relevanz bildet oder weiterhin nur als besondere Differenzierungsvariante in der Gruppe der "nichtkleinzelligen Karzinome" zu führen ist. Dieser Fragenkomplex kann künftig nur durch gezielte Studien zu Krankheitsverläufen und Therapieergebnissen geklärt werden.
Abstract
Neuroendocrine tumors of the lung can be seen as a separate entity, in accordance with the recommendations of the WHO classification of 1999, in terms of immunohistochemical findings in biopsy material as well as in more extensive resections.
The characterization of carcinoid tumors and small cell lung cancer by the pathologist according to histomorphological and cytological criteria is commonly accepted, and is of decided importance with regard to clinical questions and therapeutic measures.
However, it is still unclear whether the "new" group of large cell neuroendocrine carcinomata of the lung has to be regarded as a separate entity with clinical and therapeutic relevance, or whether this group remains within the non-small cell lung cancers as a special form of differentiation.
These complex questions can only be answered by studies targeting the course of the disease and the results of therapy.
Literatur
Bombi JA, Martinez A, Ramirez J et al. (2002) Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature. Ultrastruct Pathol 26: 211–218
Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y (2001) The new World Health Organization classification of lung tumours. Eur Respir J 18: 1059–1068
Cervilli LA, Ritter JH, Mills SE, Wick MR (2001) Neuroendocrine neoplasms of the lung. Am J Clin Pathol 116 Suppl: S65–S96
Gonzales S, von Bassewitz DB, Grundmann E, Nakhosteen JA, Müller K-M (1986) The ultrastructural heterogeneity of potentially preneoplastic lesions in the human bronchial mucosa. Path Res Pract 181: 408–417
Gould VE, Lee I, Warren WH (1990) Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung. In: Grundmann E (ed) Diagnostic seminars in pathology. Fischer, Stuttgart, pp 162–175
Gould VE, Linnoila RI, Memoli VA, Warren WH (1983) Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest 49: 519–537
Haas V (1999) Karzinoidtumoren der Lunge—Operationsverfahren, Lymphknotendissektion, Lymphknotenstatus und Prognose. Ruhr-Universität Bochum, Medizinische Fakultät, Bochum (Dissertation)
Höfler H (1997) Neuroendokrine Tumoren der Lunge. Verh Dtsch Ges Pathol 81: 118–124
Huang Q, Muzitansky A, Mark EJ (2002) Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. Arch Pathol Lab Med 126: 545–553
Johnen G, Krismann M, Jaworska M, Müller KM (2003) CGH Befunde neuroendokriner Tumoren der Lunge. Pathologe 24:■–■
Junker K, Wiethege T, Müller KM (2000) Pathology of small-cell lung cancer. J Cancer Res Clin Oncol 126: 361–368
Kerr KM (2001) Pulmonary preinvasive neoplasias. J Clin Pathol 54: 257–271
Müller K-M, Wiethege T, Krismann M, Junker K (2002) Molekulare Pathologie bösartiger pulmonaler und pleuraler Tumoren—Teil 1: Pulmonale Tumoren. In: Ruckpaul D, Ganten D (Hrsg) Handbuch der molekularen Medizin, Bd. 10. Springer, Berlin Heidelberg New York Tokio, S 29–64
Müller K-M (1999) Neues zur Pathologie der Lungentumoren. Verh Dtsch Ges Path 83: 168–183
Müller K-M, Fisseler-Eckhoff A (1989) What's new in lung tumor heterogeneity? Path Res Pract 184: 108–115
Petersen I (1999) Genetik von Karzinomen des Respirationstraktes: Korrelation von Genotyp und Phänotyp. Verh Dtsch Ges Path 83: 195–204
Takei H, Asamura H, Maeshima A et al. (2002) Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124: 285–292
Thomas CF Jr, Tazelaar HD, Jett JR (2001) Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement. Chest 119: 1143–1150
Travis W D, Colby T V, Corrin B, Shimosato Y, Brambilla E, and collaborators from 14 countries (1999) Histological typing of lung and pleural tumors, 3rd edn. World Health Organization (Hrsg.) Springer, Berlin Heidelberg New York Tokio
Travis WD, Linnoila RI, Tsokos MG et al. (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15: 529–553
Ullmann R, Petzmann S, Sharma A, Cagle PT, Popper HH (2001) Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol 32: 1059–1063
Walch AK, Zitzelsberger HF, Aubele MM et al. (1998) Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 153: 1089–1098
Warren WH, Gould VE (2002) Neuroendocrine tumors of the bronchopulmonary tract: a reappraisal of their classification after 20 years. Surg Clin North Am 82: 525–540
Wistuba II, Gazdar AF, Minna JD (2001) Molecular genetics of small cell lung carcinoma. Semin Oncol 28: 3-13
Yesner R (2001) Heterogeneity of so-called neuroendocrine lung tumors. Exp Mol Pathol 70: 179–182
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller, KM. Neuroendokrine Tumoren der Lunge. Pathologe 24, 297–302 (2003). https://doi.org/10.1007/s00292-003-0624-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-003-0624-y